Drug Information

Drug General Information
Drug ID
D0I6XA
Former ID
DNC004384
Drug Name
(2R,3S)-3-(6-Amino-purin-9-yl)-nonan-2-ol
Synonyms
3-(6-Amino-purin-9-yl)-nonan-2-ol
Indication Discovery agent Investigative [527549]
Structure
Download
2D MOL

3D MOL
Canonical SMILES
CCCCCCC(C(C)O)N1C=NC2=C1N=CN=C2N
InChI
1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17)/t10-,11+/m1/s1
InChIKey
IOSAAWHGJUZBOG-MNOVXSKESA-N
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Inhibitor [533722]
CGMP-dependent3',5'-cyclic phosphodiesterase Target Info Inhibitor [527549]
Adenosine A2a receptor Target Info Inhibitor [533722]
KEGG Pathway Purine metabolism
cGMP-PKG signaling pathway
Morphine addictionhsa04015:Rap1 signaling pathway
Calcium signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Vascular smooth muscle contraction
Parkinson's disease
Alcoholism
NetPath Pathway TSH Signaling Pathway
Pathway Interaction Database HIF-2-alpha transcription factor network
PathWhiz Pathway Intracellular Signalling Through Adenosine Receptor A2a and Adenosine
Reactome Adenosine P1 receptors
G alpha (i) signalling eventsR-HSA-418457:cGMP effects
G alpha (s) signalling eventsR-HSA-187024:NGF-independant TRKA activation
G alpha (s) signalling events
Surfactant metabolism
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, OtherWP80:Nucleotide GPCRs
Monoamine Transport
NGF signalling via TRKA from the plasma membrane
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 527549J Med Chem. 2005 May 19;48(10):3449-62.The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases.
Ref 527549J Med Chem. 2005 May 19;48(10):3449-62.The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases.
Ref 533722J Med Chem. 1995 May 12;38(10):1720-35.Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.